MEDI 75-Design and synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived inhibitors of CC chemokine receptor 2 (CCR2)

被引：0

作者：

Xiao, Zili ^{[1
]}

Delucca, George V. ^{[1
]}

Cherney, Robert J. ^{[1
]}

Shi, Qing ^{[1
]}

Mo, Ruowei ^{[1
]}

Santella, Joseph B. ^{[1
]}

Tebben, Andrew J. ^{[2
]}

Cvijic, Mary Ellen ^{[3
]}

Zhao, Qihong ^{[4
]}

Barrish, Joel C. ^{[1
]}

Carter, Percy H. ^{[1
]}

Yang, Michael G. ^{[1
]}

机构：

[1] Bristol Myers Squibb Res & Dev, Discovery Chem, Princeton, NJ 08543 USA

[2] Bristol Myers Squibb Co, Comp Assisted Drug Design, Princeton, NJ 08543 USA

[3] Bristol Myers Squibb Co, Lead Evaluat, Res & Dev, Princeton, NJ 08543 USA

[4] Bristol Myers Squibb Co, Immunol Biol, Res & Dev, Princeton, NJ 08543 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2008年 / 236卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

75-MEDI

引用

页数：1

共 50 条

[1] Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2)
Yang, Michael G.
Xiao, Zili
Shi, Qing
Cherney, Robert J.
Tebben, Andrew J.
De Lucca, George V.
Santella, Joseph B., III
Mo, Ruowei
Cvijic, Mary Ellen
Zhao, Qihong
Barrish, Joel C.
Carter, Percy H.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (03) : 1384 - 1387
[2] Design and synthesis of 3-alkylsulfonylmethyl cyclohexylaminobenzamide-derived inhibitors of CC chemokine receptor 2 (CCR2)
Yang, Michael G.
Batt, Douglas G.
Cherney, Robert J.
Mandlekar, Sandhya
Cvijic, MaryEllen
Zhao, Qihong
Barrish, Joel C.
Carter, Percy H.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[3] Design and synthesis of 2-substituted cyclohexylaminobenzamide-derived inhibitors of CC Chemokine Receptor 2 (CCR2)
Yang, Michael G.
Barrish, Joel C.
Batt, Douglas G.
Brown, Gregory
Chen, Bang-Chi
Cherney, Robert J.
Cvijic, MaryEllen
Delucca, George V.
Duncia, John V.
Gardner, Daniel S.
Santella, Joseph B.
Shi, Qing
Srivastava, Anurag
Wang, Bei
Xiao, Zili
Zhao, Qihong
Zhao, Rulin
Carter, Percy H.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[4] Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2)
Carter, Percy H.
Brown, Gregory D.
Friedrich, Sarah R.
Cherney, Robert J.
Tebben, Andrew J.
Lo, Yvonne C.
Yang, Gengjie
Jezak, Heather
Solomon, Kimberly A.
Scherle, Peggy A.
Decicco, Carl P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (19) : 5455 - 5461
[5] Synthesis and biological evaluation of spirocyclic antagonists of CCR2 (chemokine CC receptor subtype 2)
Strunz, Ann Kathrin
Zweemer, Annelien J. M.
Weiss, Christina
Schepmann, Dirk
Junker, Anna
Heitman, Laura H.
Koch, Michael
Wuensch, Bernhard
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (14) : 4034 - 4049
[6] The presence of leukocyte CC-Chemokine receptor 2 (CCR2) in CCR2 knockout mice promotes atherogenesis
Jian, G
Van Eck, M
von der Thüsen, JH
Maeda, N
Benson, GM
Groot, PH
Van Berkel, TJ
CIRCULATION, 2003, 108 (17) : 65 - 65
[7] Inducing Receptor Degradation as a Novel Approach to Target CC Chemokine Receptor 2 (CCR2)
Zacarias, Natalia V. Ortiz
Roth, Sascha
Broekhuis, Jeremy D.
van der Es, Daan
Moreau, Kevin
Heitman, Laura H.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
[8] Discovery and profile of cyclopentylamines as inhibitors of chemokine receptor CCR2
Winters, Michael P.
O'Neill, John
Hou, Cuifen
Johnson, Dana
Sui, Zhihua
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[9] Inducing receptor degradation as a novel approach to target CC chemokine receptor 2 (CCR2)
Zacarias, Natalia Ortiz
Broekhuis, Jeremy
van der Es, Daan
Heitman, Laura H.
BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 657 - 658
[10] Novel, orally bioavailable γ-aminoamide CC chemokine receptor 2 (CCR2) antagonists
Pasternak, Alexander
Marino, Dominick
Vicario, Pasquale P.
Ayala, Julia Marie
Cascierri, Margaret A.
Parsons, William
Mills, Sander G.
MacCoss, Malcolm
Yang, Lihu
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (16) : 4801 - 4804

← 1 2 3 4 5 →